Investors & Media

Kiniksa Pharmaceuticals to Present at 36th Annual J.P. Morgan Healthcare Conference

December 21, 2017


Sanj K. Patel to Provide Update on Therapeutic Focus and Pipeline Build

HAMILTON, Bermuda, December 20, 2017 (Business Wire) — Kiniksa Pharmaceuticals, Ltd., a privately-held biotechnology company focused on developing and delivering therapeutics for patients with debilitating diseases and unmet medical needs, announced that Chairman and Chief Executive Officer, Sanj K. Patel, will present at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2018, at 12:00 p.m. PST (3:00 p.m. EST).

“The Kiniksa team has made considerable progress in building our pipeline, which now covers a spectrum of early to late stage development programs,” said Patel.  “We look forward to advancing that pipeline as we focus on programs that target orphan to larger specialty patient populations that have serious, unmet needs around the world.”

Further information regarding Kiniksa is available at www.kiniksa.com.

Contacts
Kiniksa Pharmaceuticals
Chris Heberlig, 781-430-8540
Chief Financial Officer
cheberlig@kiniksa.com